Search Ontology:
ChEBI

beta-D-GlcpNAc-(1->6)-beta-D-GlcpNAc-(1->6)-alpha-D-Galp

Term ID
CHEBI:146897
Synonyms
  • 2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->6)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->6)-alpha-D-galacto-hexopyranose
  • 2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)-alpha-D-galactopyranose
  • GlcNAc(b1-6)GlcNAc(b1-6)a-Gal
  • N-[(2R,3R,4R,5S,6R)-2-[[(2R,3S,4R,5R,6R)-5-acetamido-3,4-dihydroxy-6-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-2-yl]methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
Definition
An amino trisaccharide consisting of two 2-acetamido-2-deoxy-β-D-glucopyranose residues and an α-D-galactopyranose residue joined in sequence by (1→6) glycosidic bonds.
References
  • glygen:G05964BT
  • glytoucan:G05964BT
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-GlcpNAc-(1->6)-beta-D-GlcpNAc-(1->6)-alpha-D-Galp
Phenotype where environments contain beta-D-GlcpNAc-(1->6)-beta-D-GlcpNAc-(1->6)-alpha-D-Galp
Phenotype modified by environments containing beta-D-GlcpNAc-(1->6)-beta-D-GlcpNAc-(1->6)-alpha-D-Galp
Phenotype affecting beta-D-GlcpNAc-(1->6)-beta-D-GlcpNAc-(1->6)-alpha-D-Galp
Human Disease Model